These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38005269)

  • 21. Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.
    Aley KO; Levine JD
    J Neurosci; 1997 Jan; 17(2):735-44. PubMed ID: 8987795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.
    Wang YJ; Tao YM; Li FY; Wang YH; Xu XJ; Chen J; Cao YL; Chi ZQ; Neumeyer JL; Zhang A; Liu JG
    J Pharmacol Exp Ther; 2009 Apr; 329(1):306-13. PubMed ID: 19136637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine.
    Chao PK; Chang HF; Chang WT; Yeh TK; Ou LC; Chuang JY; Tsu-An Hsu J; Tao PL; Loh HH; Shih C; Ueng SH; Yeh SH
    Neuropharmacology; 2020 Apr; 166():107678. PubMed ID: 31278929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synaptic mechanism for functional synergism between delta- and mu-opioid receptors.
    Zhang Z; Pan ZZ
    J Neurosci; 2010 Mar; 30(13):4735-45. PubMed ID: 20357124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
    Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
    Bedini A; Baiula M; Gentilucci L; Tolomelli A; De Marco R; Spampinato S
    Peptides; 2010 Nov; 31(11):2135-40. PubMed ID: 20713109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro and In Vivo Pharmacological Profiles of LENART01, a Dermorphin-Ranatensin Hybrid Peptide.
    Hochrainer N; Serafin P; D'Ingiullo S; Mollica A; Granica S; Brytan M; Kleczkowska P; Spetea M
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of Cdk5-associated phosphorylation of residue threonine-161 of the delta-opioid receptor: impaired receptor function and attenuated morphine antinociceptive tolerance.
    Xie WY; He Y; Yang YR; Li YF; Kang K; Xing BM; Wang Y
    J Neurosci; 2009 Mar; 29(11):3551-64. PubMed ID: 19295160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and Structure-Activity Relationships of 5'-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with Systemic Antinociceptive Activity and Diminished Opioid Side Effects.
    Vekariya RH; Lei W; Ray A; Saini SK; Zhang S; Molnar G; Barlow D; Karlage KL; Bilsky EJ; Houseknecht KL; Largent-Milnes TM; Streicher JM; Ananthan S
    J Med Chem; 2020 Jul; 63(14):7663-7694. PubMed ID: 32530286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.
    Giri AK; Apostol CR; Wang Y; Forte BL; Largent-Milnes TM; Davis P; Rankin D; Molnar G; Olson KM; Porreca F; Vanderah TW; Hruby VJ
    J Med Chem; 2015 Nov; 58(21):8573-83. PubMed ID: 26465170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of Analgesic Trivalent Peptides with Low Withdrawal Symptoms: Probing the Antinociceptive Profile of Novel Linear and Cyclic Peptides as Opioid Pan Ligands.
    Stefanucci A; Minosi P; Pieretti S; Tanguturi P; Molnar G; Scioli G; Marinaccio L; Della Valle A; Streicher JM; Mollica A
    ACS Chem Neurosci; 2023 Feb; 14(3):506-515. PubMed ID: 36651179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
    Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
    Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzylideneoxymorphone: A new lead for development of bifunctional mu/delta opioid receptor ligands.
    Healy JR; Bezawada P; Griggs NW; Devereaux AL; Matsumoto RR; Traynor JR; Coop A; Cunningham CW
    Bioorg Med Chem Lett; 2017 Feb; 27(3):666-669. PubMed ID: 28011222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene.
    Chen SL; Ma HI; Han JM; Lu RB; Tao PL; Law PY; Loh HH
    J Biomed Sci; 2010 Apr; 17(1):28. PubMed ID: 20403204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities.
    Healy JR; Bezawada P; Shim J; Jones JW; Kane MA; MacKerell AD; Coop A; Matsumoto RR
    ACS Chem Neurosci; 2013 Sep; 4(9):1256-66. PubMed ID: 23713721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
    Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
    Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzylaminofentanyl derivates: Discovery of bifunctional μ opioid and σ
    Zhuang T; Xiong J; Ren X; Liang L; Qi Z; Zhang S; Du W; Chen Y; Liu X; Zhang G
    Eur J Med Chem; 2022 Nov; 241():114649. PubMed ID: 35961067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pentapeptides displaying mu opioid receptor agonist and delta opioid receptor partial agonist/antagonist properties.
    Purington LC; Pogozheva ID; Traynor JR; Mosberg HI
    J Med Chem; 2009 Dec; 52(23):7724-31. PubMed ID: 19788201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH
    Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A
    Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.